Anti-HYLS1/ HLS monoclonal antibody

Anti-HYLS1/ HLS antibody for FACS & in-vivo assay

Target products collectionGo to HYLS1/HYLS1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2163-Ab-1/ GM-Tg-hg-MP2163-Ab-2Anti-Human HYLS1 monoclonal antibodyHuman
GM-Tg-rg-MP2163-Ab-1/ GM-Tg-rg-MP2163-Ab-2Anti-Rat HYLS1 monoclonal antibodyRat
GM-Tg-mg-MP2163-Ab-1/ GM-Tg-mg-MP2163-Ab-2Anti-Mouse HYLS1 monoclonal antibodyMouse
GM-Tg-cynog-MP2163-Ab-1/ GM-Tg-cynog-MP2163-Ab-2Anti-Cynomolgus/ Rhesus macaque HYLS1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2163-Ab-1/ GM-Tg-felg-MP2163-Ab-2Anti-Feline HYLS1 monoclonal antibodyFeline
GM-Tg-cang-MP2163-Ab-1/ GM-Tg-cang-MP2163-Ab-2Anti-Canine HYLS1 monoclonal antibodyCanine
GM-Tg-bovg-MP2163-Ab-1/ GM-Tg-bovg-MP2163-Ab-2Anti-Bovine HYLS1 monoclonal antibodyBovine
GM-Tg-equg-MP2163-Ab-1/ GM-Tg-equg-MP2163-Ab-2Anti-Equine HYLS1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2163-Ab-1/ GM-Tg-hg-MP2163-Ab-2; GM-Tg-rg-MP2163-Ab-1/ GM-Tg-rg-MP2163-Ab-2;
GM-Tg-mg-MP2163-Ab-1/ GM-Tg-mg-MP2163-Ab-2; GM-Tg-cynog-MP2163-Ab-1/ GM-Tg-cynog-MP2163-Ab-2;
GM-Tg-felg-MP2163-Ab-1/ GM-Tg-felg-MP2163-Ab-2; GM-Tg-cang-MP2163-Ab-1/ GM-Tg-cang-MP2163-Ab-2;
GM-Tg-bovg-MP2163-Ab-1/ GM-Tg-bovg-MP2163-Ab-2; GM-Tg-equg-MP2163-Ab-1/ GM-Tg-equg-MP2163-Ab-2
Products NameAnti-HYLS1 monoclonal antibody
Formatmab
Target NameHYLS1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HYLS1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species HYLS1/ HLS VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004911human HYLS1 Lentivirus particle
    ORF Viral VectorpGMLP004911human HYLS1 Lentivirus plasmid
    ORF Viral VectorpGMLPm003345mouse Hyls1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003345mouse Hyls1 Lentivirus particle


    Target information

    Target IDGM-MP2163
    Target NameHYLS1
    Gene ID219844,76832,680262,713815,609650,101086747,538735,100064444
    Gene Symbol and Synonyms3010015K02Rik,HLS,HYLS1
    Uniprot AccessionQ96M11,Q2KI52
    Uniprot Entry NameHYLS1_HUMAN,HYLS1_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000198331
    Target ClassificationN/A

    The target: HYLS1, gene name: HYLS1, also named as HLS. This gene encodes a protein localized to the cytoplasm. Mutations in this gene are associated with hydrolethalus syndrome. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.